Frank Leipold is a product and business model innovator, with a track record of developing and launching new medical devices and therapies. He lead the first AI project at a global dialysis provider, resulting in a clinical decision support system for physicians. Its quality and success was based on the abundance of patient data available in dialysis, reinforcing the need for collecting data at the point of care. He holds a BSc from TH Nuremberg and an MBA from University of Cambridge.